NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)

The summary for the NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional): The Small Business Innovation Research (SBIR) program helps United States small business concerns (SBCs) bring scientific innovations to the marketplace. The SBIR program supports feasibility studies to later research and development (R&D) needed to develop a commercial product.

Federal Grant Title:	NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PA-27-100
Type of Funding:	Grant
CFDA Numbers:	93.068, 93.070, 93.073, 93.083, 93.084, 93.103, 93.113, 93.121, 93.136, 93.142, 93.143, 93.172, 93.173, 93.213, 93.233, 93.242, 93.273, 93.279, 93.286, 93.307, 93.313, 93.326, 93.350, 93.351, 93.361, 93.393, 93.394, 93.395, 93.837, 93.838, 93.839, 93
CFDA Descriptions:	Information not provided
Current Application Deadline:	April 5th, 2027
Original Application Deadline:	April 5th, 2027
Posted Date:	May 28th, 2026
Creation Date:	May 28th, 2026
Archive Date:	June 4th, 2027
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	May 28th, 2026

Applicants Eligible for this Grant: Small businesses
Additional Information on Eligibility: Only United States small business concerns (SBCs), as defined by the Small Business Administration (SBA)(sbir.gov/apply) are eligible to submit applications for this opportunity.Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Unfunded international collaborations or unfunded foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Grant Announcement Contact: NIH SEED (Small business Education and Entrepreneurial Development)
[email protected]
NIH SEED (Small business Education and Entrepreneurial Development)
Similar Government Grants: • Epilepsy Incidence Among Children in the United States; • Effectiveness of Telehealth-Based Programs to Detect Glaucoma Among High-Risk Populations ...; • PHS 2022-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Rese...; • PHS 2022-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research ...; • Assessing the Effectiveness of Programs, Policies, or Practices that Affect Social Determi...; • Diabetes Prevention and Control in the Americas; • Demonstration Project for Identifying Individuals at High-Risk for Chronic Kidney Disease ...; • Assessment of Proposed Revisions to the Youth Tobacco Survey: Impact on Measures of Youth ...
More Grants from the National Institutes of Health: • HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery R...; • Single Source Competition: Continuation of the Cardiovascular Repository for Type 1 Diabet...; • Metastasis Research Network (U54 Clinical Trial Not Allowed); • Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U0...; • Causal Hypotheses on the Oral-Systemic Health Impacts of Human Behaviors among People with...